The Department of Veterans Affairs Cooperative Studies Program - PowerPoint PPT Presentation

About This Presentation
Title:

The Department of Veterans Affairs Cooperative Studies Program

Description:

Steve Goldman, M.D. ClinicalTrials.gov number, NCT00054847 A Randomized Trial Radial Artery Graft vs. Saphenous Vein Grafts In CABG Tucson VA Hospital I have no ... – PowerPoint PPT presentation

Number of Views:91
Avg rating:3.0/5.0
Slides: 20
Provided by: Yvet5
Category:

less

Transcript and Presenter's Notes

Title: The Department of Veterans Affairs Cooperative Studies Program


1
The Department of Veterans Affairs
Cooperative Studies Program
  • Steve Goldman, M.D.
  • ClinicalTrials.gov number, NCT00054847

2
A Randomized Trial Radial Artery Graft vs.
Saphenous Vein Grafts In CABG
Tucson VA Hospital
3
Disclosure
  • I have no financial conflict of interest for
  • this study.

4
Background
  • Arterial grafts - better conduits than veins
    LIMA
  • Other arterial grafts
  • Right internal/free internal mammary,
    gastroepiploic, splenic
  • Radial artery - easiest to harvest, most popular
  • 2008 - STS data base
  • 163,048 CABG
  • 10,319 radial artery grafts
  • Problem - patency radial artery grafts not clear

5
Methods
  • Prospective randomized trial
  • One year angiographic patency Radial Artery (RA)
    vs Saphenous Vein (SV)
  • 11 VA medical centers (2003-2008)
  • 733 patients randomized
  • RA 366
  • SV - 367
  • Study graft either RA or SV

6
CSP-474 Study Sites












Albuquerque Hines New Orleans Ann
Arbor Houston Richmond Birmingham Little
Rock Tucson West Roxbury Minneapolis
7
Hypothesis
  • Radial artery better patency
  • Proposed-one-year rates
  • 92 RA
  • 83 SV

Goldman et al, 1988-1994 CSPs
207/297/364, 2004
8
Statistics
  • 90 power with a two-sided type I error of 5
  • Expected one-year catheterization completion rate
    of 65
  • Final enrollment
  • 733 patients, originally planned 874
  • One-year catheterization completion rate (73)
  • Higher than expected
  • Post hoc power 89 to detect 92 RA vs 83 SV

9
Primary End Point
10
Secondary Endpoints
  • Selective graft patency (RA vs SV)
  • LAD 83 vs 88
  • CX 93 vs 89
  • RCA 86 vs 88
  • No differences

11
Secondary Endpoints
  • Disease in grafts
  • More high grade disease (string sign)
  • RA - 8 vs SV - 1, (Plt0.001)
  • Endoscopic harvesting
  • SV - lower patency 78 vs 91, (P0.009)
  • N 72
  • RA - no difference 100 vs 89
  • N 18

12
Complications
7.6 SYNTAX Serruys et al., NEJM 360961-972
2009
13
Other Analyses
  • On pump vs off pump
  • RA - no difference patency (89 vs 89)
  • SV - higher patency on pump (90 vs 78)
  • Off pump numbers small RA n41 vs SV n48
  • Quality of life
  • No difference at 3 months or 12 months

14
Costs
15
Discussion
The other prospective randomized study RAPS
(Desai et.al NEJM 2004).
  • CSP-474
  • Randomized RA or SV
  • Surgeon chose recipient vessel
  • RAPS
  • Both RA and SV as study grafts
  • Randomized to recipient vessel

16
Discussion Cont.
  • CSP-474
  • One year patency no difference
  • RA 89 vs SV 89
  • Best recipient vessel was study vessel
  • We can define
  • Patient characteristics
  • Isolate complications
  • One week cath/monitor disease progression
  • RAPS
  • One year patency, RA better
  • RA - 92 vs SV - 86
  • Fewer patients required
  • Cannot separate complications

17
Conclusion
  • No difference in radial artery graft vs saphenous
    vein graft at one year
  • Our study group funded by VA Cooperative Studies
    Program for five year angiographic follow up

18
CSP 474 Study Group
  • Gulshan Sethi, M.D.,
  • William Holman, M.D.
  • Kelvin Lee, Ph.D.
  • Stephen Fremes, M.D.
  • Hoang Thai, M.D.
  • Todd Wagner Ph.D.
  • Yajie Wang, M.S.
  • Lori Planting, B.A.
  • Meredith Miller, M.A.
  • Yvette Rodriguez, R.N.
  • Elizabeth Juneman, M.D.
  • Douglas Morrison, M.D.
  • Mary Kaye Pierce, N.P.
  • Sandra Kreamer R.N.
  • Mei-Chiung Shih, Ph.D.
  • Edward McFalls M.D.
  • Herb Ward, M.D.
  • Rose Kelly, M.D.
  • Birger Rhenman, M.D.
  • Gareth Tobler, M.D.
  • Faisal G. Bakaeen, M.D.
  • Mohammed Moursi, M.D.
  • Michael Crittenden, M.D.
  • Vigneshwar Kasirajan, M.D.
  • Claire Duvernoy, M.D.
  • Stewart Pett, M.D.
  • Michelle Ratliff, M.D.
  • Anand Irimpen, M.D.
  • William Gunnar, M.D.
  • Donald Thomas, M.D.
  • Thomas Moritz, M.S.
  • Domenic Reda, Ph.D.
  • Lynn Harrison, M.D.

19
BASTA!
Write a Comment
User Comments (0)
About PowerShow.com